Fujisawa Masayoshi

フジサワマサヨシ | Fujisawa Masayoshi

Affiliation and department：

Research field (1)： Human pathology

Research keywords (4)： blood vessel invasion , immunohistochemistry , cancer microenvironment , breast cancer

Research theme for competitive and other funds (1)：

2023 - 2026 AI病理診断に向けた、組織切片の厚さの簡易計測法の開発と標準化技術の確立

Papers (39)：

大原利章, 陳悦華, 王宇沢, 濱田祐輔, 菊地覚次, 野間和広, 田澤大, 藤澤真義, 藤原俊義, 松川昭博. 鉄キレート効果を持つHIF-PH阻害薬は抗腫瘍免疫応答を向上させる(HIF-PH inhibitors with iron chelating ability enhance the tumor immune response). 日本癌学会総会記事. 2023. 82回. 248-248
Tong Gao, Xu Yang, Masayoshi Fujisawa, Toshiaki Ohara, Tianyi Wang, Nahoko Tomonobu, Masakiyo Sakaguchi, Teizo Yoshimura, Akihiro Matsukawa. SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells. International journal of molecular sciences. 2023. 24. 5
Yuze Wang, Toshiaki Ohara, Yuehua Chen, Yusuke Hamada, Chunning Li, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa. Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators. Cancers. 2023. 15. 2. 468
Chunning Li, Teizo Yoshimura, Miao Tian, Yuze Wang, Takamasa Kondo, Ken-Ichi Yamamoto, Masayoshi Fujisawa, Toshiaki Ohara, Masakiyo Sakaguchi, Akihiro Matsukawa. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer. Breast cancer research : BCR. 2022. 24. 1. 60-60
Hiroyuki Miyahara, Kosei Hasegawa, Masato Yashiro, Toshiaki Ohara, Masayoshi Fujisawa, Teizo Yoshimura, Akihiro Matsukawa, Hirokazu Tsukahara. Author Correction: Thioredoxin interacting protein protects mice from fasting induced liver steatosis by activating ER stress and its downstream signaling pathways. Scientific reports. 2022. 12. 1. 8026-8026

ｍore...

MISC (75)：

王天偉, 高桐, 藤澤真義, 大原利章, 吉村禎造, 松川昭博. HCC細胞のオートファジーにおけるSpred2の機能及びmTORC1活性化との関係(Role of Spred2 in autophagy in HCC cells and its relation to mTORC1 activation). 日本病理学会会誌. 2023. 112. 1. 238-238
王宇沢, 大原利章, チン・ユエファ, 浜田祐輔, 李春寧, 藤澤真義, 松川昭博. TNBCにおける転移能の獲得と鉄代謝の変動(Changes in iron metabolism associated with the acquisition of metastatic potential in TNBC cells). 日本病理学会会誌. 2023. 112. 1. 240-240
Tian Miao, 吉村禎造, 李春寧, 大原利章, 藤澤真義, 松川昭博. 腫瘍環境のSpred2欠損は乳がんの増殖と転移を抑制する(Spred2 deficiency in the tumor microenvironment inhibits the progression of breast cancer in mice.). 日本病理学会会誌. 2023. 112. 1. 304-304
高桐, 田ミョウ, 藤澤真義, 大原利章, 王天偉, 李春寧, 王宇沢, トウン・ティンダ・ニン, 吉村禎造, 松川昭博. SPRED2は食道がん細胞のマクロファージを、エクソソームのIL6/STAT3を介して、M2表現形に分化させる(SPRED2 polarizes macrophages into M2 phenotype via exosomal IL-6/STAT3 axis in esophageal carcinoma). 日本病理学会会誌. 2023. 112. 1. 354-354
浜田祐輔, 大原利章, WANG Yuze, CHEN Yuehua, 藤澤真義, 木村文昭, 松川昭博. 肺がんに対する鉄キレート剤を用いた抗腫瘍免疫応答の向上. 日本鉄バイオサイエンス学会学術集会プログラム・抄録集. 2023. 47th

ｍore...

Books (1)：

リンパ組織
文光堂 2023 ISBN:9784830604911

Lectures and oral presentations (5)：

The role of Spred2 in lung adenocarcinoma
(2022)
Double immunostaining for tumor vessel identification and its application in breast cancer prognosis
(2022)
Interclonal Cooperation by Exosomal Wnt7a Promotes Lung Metastasis of the 4T1 Breast Cancer cells
(2022)
Pseudo-hypoxia by iron chelators consists anti-cancer effect and CD8+ T-cell activation
(2022)
Spred2 regulates stemness in HCC, partly targeting on miR-506- 3p/KLF4/Stat3 signaling
(2022)

Professional career (1)：

医学博士 ( 岡山大学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page